Skip to main content

Advertisement

Log in

Improvement of pelvic floor-related quality of life and sexual function after vaginal mesh implantation for cystocele: primary endpoint of a prospective multicentre trial

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Pelvic organ prolapse (POP) impairs quality of life (QoL) due to vaginal bulge symptoms and changes in bladder/bowel and sexual function. The effect of alloplastic meshes on QoL is still being discussed. The purpose of this study was to prospectively evaluate the effect of mesh implantation on QoL and sexual function over 1 year.

Methods

289 women with cystocele > stage I were included in this prospective multicenter study, with nine hospitals participating (ClinicalTrials.gov NCT01084889). Mesh exposures rates and pelvic floor-related QoL using the validated German version of the p-QoL questionnaire were evaluated as the primary endpoints. Based on a single-sided binominal test with α = 0.05 and a power of 0.80, a sample size of 225 for the mesh exposures was calculated. The mesh used was a 6-arm mesh with titanium coating (TILOOP® Total 6, sponsor pfm medical ag, Germany). Preoperative data were compared to 6 and 12 months postoperative data, using Wilcoxon test.

Results

The mean age of the patients was 67 years (min 43, max 87). All domains of QoL improved significantly compared after surgery: mean prolapse score dropped from 73.7 to 19.4 after 6 and 16.2 after 12 months (p < 0.001). Sexual function also improved significantly. The rate of dyspareunia was lower at follow-up.

Conclusions

In this prospective trial, a significant positive effect of mesh implantation on pelvic floor-related QoL was observed. These findings remained stable 1 year after surgery with further improvement. This trial adds further data to the ongoing discussion on the role and risk of meshes in POP surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

POP:

Pelvic organ prolapse

QoL:

Quality of life

FDA:

US food and drug administration

eCRF:

Electronic case report form

MCID:

Minimal clinically important difference

POP-Q:

Pelvic organ prolapse quantification system

References

  1. Jelovsek JE, Maher C, Barber MD (2007) Pelvic organ prolapse. Lancet 369(9566):1027

    Article  PubMed  Google Scholar 

  2. Karabulut A, Ozkan S, Koçak N, Alan T (2014) Evaluation of confounding factors interfering with sexual function in women with minimal pelvic organ prolapse. Int J Gynaecol Obstet 127(1):73–76

    Article  PubMed  Google Scholar 

  3. Maher C, Feiner B, Baessler K, Schmid C (2013) Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 4:CD004014. doi:10.1002/14651858.CD004014.pub5

    PubMed  Google Scholar 

  4. FDA Safety Communication (2013) Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. http://www.fda.gov/medicaldevices/safety/alertsandnotices/publichealthnotifications/ucm061976.htm

  5. Köckerling F, Schug-Pass C (2014) What do we know about titanized polypropylene meshes? An evidence-based review of the literature. Hernia 18(4):445–457. doi:10.1007/s10029-013-1187-3 (Epub 2013 Nov 20. Review)

    Article  PubMed  Google Scholar 

  6. Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S (2005) P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct 16(3):176–181

    Article  PubMed  Google Scholar 

  7. Lenz F, Stammer H, Brocker K, Rak M, Scherg H, Sohn C (2009) Validation of a German version of the P-QOL questionnaire. Int Urogynecol J Pelvic Floor Dysfunct 20(6):641–649. doi:10.1007/s00192-009-0809-x

    Article  CAS  PubMed  Google Scholar 

  8. Brosteanu O, Houben P, Ihrig K, Ohmann C, Paulus U, Pfistner B, Schwarz G, Strenge-Hesse A, Zettelmeyer U (2009) Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials. Clin Trials. 6(6):585–596. doi:10.1177/1740774509347398

    Article  PubMed  Google Scholar 

  9. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582–592

    PubMed  Google Scholar 

  10. http://www.g-drg.de/cms/

  11. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2015) Preliminary Opinion on the safety of surgical meshes used in urogynecological surgery. European Union, 2015. ISSN 1831-4783 ISBN 978-92-79-43917-9. doi:10.2772/63702

  12. Barber MD, Brubaker L, Nygaard I, Wheeler TL 2nd, Schaffer J, Chen Z, Spino C (2009) Pelvic floor disorders network. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol 114(3):600–609. doi:10.1097/AOG.0b013e3181b2b1ae

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zyczynski HM, Rickey L, Dyer KY, Wilson T, Stoddard AM, Gormley EA, Hsu Y, Kusek JW, Brubaker L (2012) Urinary incontinence treatment network. Sexual activity and function in women more than 2 years after midurethral sling placement. Am J Obstet Gynecol 207(5):421.e1–6

  14. Rogers RG, Kammerer-Doak D, Darrow A, Murray K, Olsen A, Barber M, Qualls C (2004) Does sexual function change after surgery for stress urinary incontinence and/or pelvic organ prolapse? A multicenter prospective study. Am J Obstet Gynecol 191:206–210

    Article  PubMed  Google Scholar 

  15. Barski D, Otto T, Gerullis H (2014) Systematic review and classification of complications after anterior, posterior, apical, and total vaginal mesh implantation for prolapse repair. Surg Technol Int 24:217–224

    PubMed  Google Scholar 

  16. Marschke J, Hengst L, Schwertner-Tiepelmann N, Beilecke K, Tunn R (2015) Transvaginal single-incision mesh reconstruction for recurrent or advanced anterior vaginal wall prolapse. Arch Gynecol Obstet 291(5):1081–1087. doi:10.1007/s00404-014-3497-9 (Epub 2014 Oct 4)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Mr. Arim Shukri for the statistical analysis and Mr. Lutz Sternfeld for the external monitoring.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juliane Farthmann.

Ethics declarations

Funding

The study was sponsored by pfm medical ag, Cologne, Germany.

Conflict of interest

We have had full control of all primary data and agree to allow the Journal to review our data if requested.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farthmann, J., Mengel, M., Henne, B. et al. Improvement of pelvic floor-related quality of life and sexual function after vaginal mesh implantation for cystocele: primary endpoint of a prospective multicentre trial. Arch Gynecol Obstet 294, 115–121 (2016). https://doi.org/10.1007/s00404-016-4014-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-016-4014-0

Keywords

Navigation